卡孕栓防治妊娠期高血压疾病产后出血的疗效观察

目的观察卡孕栓用于防治妊娠期高血压疾病产后出血的效果。方法选择住院分娩的妊娠期高血压疾病患者210例,孕38～41周。随机分为观察组和对照组,分别用卡孕栓配合催产素和单用催产素。结果观察组产后出血发生率、产后2小时及24小时出血量均低于对照组,两组比较有显著性差异（P〈0.05）;观察组用药后收缩压与舒张压稍有降低,但两组比较无显著差异（P〉0.05）。结论卡孕栓配合催产素防治妊娠期高血压疾病产后出血,疗效显著,且安全方便。

Clinical observation of Methyl Carboprost Suppository for preventing and treating postpartum hemorrhage caused by hypertensive disorders in pregnancy

Objective To study the effect of methyl carboprost suppository on preventing and treating postpartum hemorrhage caused by hypertensive disorder in pregnancy. Methods 210 patients in 38～41 gestational weeks with hypertensive disorders in pregnancy were randomly divided into observation group and control group. The patients were treated with methyl carboprost suppository combined with oxytocin in observation group and other patients were treated with oxytocin alone in control group. Results The occurrence of bleeding and the volume of bleeding within 2-hour and 24-hour after delivery were less in observation group than that in control group and there was significant difference between two groups（P0.05）. The systolic pressure and diastolic pressure of patients declined a little in observation group but there was no significant difference（P0.05）. Conclusion It was safe and convenient to effectively treat patients with postpartum hemorrhage caused by hypertensive disorder in pregnancy of methyl carboprost suppository combined with oxytocin.